Latest Guidelines for Combination Products Registration - 2017

Overview:

During this introductory session, delegates will gain a complete guide to the status and impact of the latest guidelines for combination products.

Why should you Attend: 

This webinar will examine the regulatory requirements for drug device combinations in the case of a drug and a device and for integral products.This webinar will cover the basic requirements of how to stay compliant. 

Areas Covered in the Session:

Interfacing,Development,Quality,Regulatory

Managing third parties and document control

Vigilance and adverse event reporting

Who Will Benefit:

Regulatory Affairs

Medical Officers

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: support@compliance4All.com

Speaker Profile:

Salma Michor , PhD, MSc, MBA, CMgr, RAC is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH.